COMPANY

Bambusa Therapeutics

Location: Boston, MA · source · Feb 26, 2025

Profile checked Oct 10, 2026

Keywords: Atopic Dermatitis Chronic Rhinosinusitis With Nasal Polyps Chronic Obstructive Pulmonary Disease Chronic Spontaneous Urticaria BBT001 BBT002

6Trials (company is sponsor)

Timeline

Jun 29, 2026 Trial start Phase 1/Phase 2: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 Following Intravenous Administration in Participants W source ↗
Mar 2, 2026 Trial start Phase 1/Phase 2: A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma source ↗
Sep 5, 2025 Trial start Phase 1: A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD) source ↗
Aug 9, 2025 Trial start Phase 1: A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD) source ↗
May 8, 2025 Trial start Phase 1: A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP) source ↗
Feb 27, 2025 Trial start Phase 1: A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD) source ↗

Upcoming milestones

Dec 31, 2026 (ESTIMATED) · Phase 1 · A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD) · NCT07288554
Jan 31, 2027 (ESTIMATED) · Phase 1 · A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP) · NCT06944925
Feb 28, 2027 (ESTIMATED) · Phase 1 · A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD) · NCT06808477
Dec 31, 2027 (ESTIMATED) · Phase 1/Phase 2 · A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma · NCT07436949
Dec 31, 2027 (ESTIMATED) · Phase 1/Phase 2 · A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 Following Intravenous Administration in Participants With Chronic Spont · NCT07717905
Dec 31, 2027 (ESTIMATED) · Phase 1 · A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD) · NCT07239947

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 6

Record	Title	Phase	Status	Start	Primary completion
NCT06808477	A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)	Phase 1	Recruiting	Feb 27, 2025	Feb 28, 2027 (estimated)
NCT07436949	A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma	Phase 1/Phase 2	Recruiting	Mar 2, 2026	Dec 31, 2027 (estimated)
NCT07288554	A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)	Phase 1	Recruiting	Sep 5, 2025	Dec 31, 2026 (estimated)
NCT07717905	A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 Following Intravenous Administration in Participants With Chronic Spontaneous Urticaria (CSU)	Phase 1/Phase 2	Recruiting	Jun 29, 2026	Dec 31, 2027 (estimated)
NCT07239947	A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)	Phase 1	Recruiting	Aug 9, 2025	Dec 31, 2027 (estimated)
NCT06944925	A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)	Phase 1	Recruiting	May 8, 2025	Jan 31, 2027 (estimated)